My opinion is that there is little interest and confidence the moment for Canning exploration. I believe the buyers aren't in it for y2, but for corporate reasons.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025